Impact of bleeding and bivalirudin therapy on mortality risk in women undergoing percutaneous coronary intervention (from the REPLACE-2, ACUITY, and HORIZONS-AMI Trials)

American Journal of Cardiology

Volumn 117, Issue 2, 2016, Pages 186-191

  Ng, Vivian G ^a   Baumbach, Andreas ^b   Grinfeld, Liliana ^c   Lincoff, A Michael ^d   Mehran, Roxana ^e   Stone, Gregg W ^e   Lansky, Alexandra J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

^c HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^d LERNER RESEARCH INSTITUTE   (United States)

^e New York Presbyterian Morgan Stanley Children's Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; ANTITHROMBIN; HIRUDIN DERIVATIVE; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BLEEDING; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SEX DIFFERENCE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURVIVAL RATE; TREATMENT INDICATION; ARGENTINA; CHEMICALLY INDUCED; CLINICAL TRIAL; ELECTROCARDIOGRAPHY; EPIDEMIOLOGY; FOLLOW UP; GREAT BRITAIN; MULTICENTER STUDY; MYOCARDIAL INFARCTION; PROCEDURES; TIME FACTOR; TRENDS; UNITED STATES;

AGED; ANTITHROMBINS; ARGENTINA; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HEMORRHAGE; HIRUDINS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PEPTIDE FRAGMENTS; PERCUTANEOUS CORONARY INTERVENTION; RECOMBINANT PROTEINS; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; UNITED STATES;

EID: 84950261262     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.10.029     Document Type: Article

References (30)

1. C. Cheng, K.H. Yeh, H.W. Chang, T.H. Yu, Y.H. Chen, H.T. Chai, and H.K. Yip Comparison of baseline characteristics, clinical features, angiographic results, and early outcomes in men vs women with acute myocardial infarction undergoing primary coronary intervention Chest 126 2004 47 53
2. K.M. King, W.A. Ghali, P.D. Faris, M.J. Curtis, P.D. Galbraith, M.M. Graham, and M.L. Knudtson Sex differences in outcomes after cardiac catheterization: effect modification by treatment strategy and time JAMA 291 2004 1220 1225
3. B.A. Vakili, R.C. Kaplan, and D.L. Brown Sex-based differences in early mortality of patients undergoing primary angioplasty for first acute myocardial infarction Circulation 104 2001 3034 3038
4. D. Radovanovic, P. Erne, P. Urban, O. Bertel, H. Rickli, and J.M. Gaspoz Gender differences in management and outcomes in patients with acute coronary syndromes: results on 20,290 patients from the AMIS Plus Registry Heart 93 2007 1369 1375
5. M. Moscucci, K.A. Fox, C.P. Cannon, W. Klein, J. Lopez-Sendon, G. Montalescot, K. White, and R.J. Goldberg Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE) Eur Heart J 24 2003 1815 1823
6. E. Argulian, A. Patel, J.L. Abramson, A. Kulkarni, K. Champney, S. Palmer, W. Weintraub, N.K. Wenger, and V. Vaccarino Gender differences in short-term cardiovascular outcomes after percutaneous coronary interventions Am J Cardiol 98 2006 48 53
7. F. Feit, M.D. Voeltz, M.J. Attubato, A.M. Lincoff, D.P. Chew, J.A. Bittl, E.J. Topol, and S.V. Manoukian Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 Trial Am J Cardiol 100 2007 1364 1369
8. T.D. Kinnaird, E. Stabile, G.S. Mintz, C.W. Lee, D.A. Canos, N. Gevorkian, E.E. Pinnow, K.M. Kent, A.D. Pichard, L.F. Satler, N.J. Weissman, J. Lindsay, and S. Fuchs Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions Am J Cardiol 92 2003 930 935
9. T. Huynh, P. Theroux, S. Snapinn, and Y. Wan Effect of platelet glycoprotein IIb/IIIa receptor blockade with tirofiban on adverse cardiac events in women with unstable angina/non-ST-elevation myocardial infarction (PRISM-PLUS Study) Am Heart J 146 2003 668 673
10. EPILOG Investigators Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization N Engl J Med 336 1997 1689 1696
11. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. The EPIC Investigation N Engl J Med 330 1994 956 961
12. L.S. Fernandes, J.E. Tcheng, J.C. O'Shea, B. Weiner, T.J. Lorenz, C. Pacchiana, L.G. Berdan, K.J. Maresh, D. Joseph, M. Madan, T. Mann, R. Kilaru, J.S. Hochman, and N.S. Kleiman Is glycoprotein IIb/IIIa antagonism as effective in women as in men following percutaneous coronary intervention? Lessons from the ESPRIT study J Am Coll Cardiol 40 2002 1085 1091
13. L. Cho, E.J. Topol, C. Balog, J.M. Foody, J.E. Booth, C. Cabot, N.S. Kleiman, J.E. Tcheng, R. Califf, and A.M. Lincoff Clinical benefit of glycoprotein IIb/IIIa blockade with abciximab is independent of gender: pooled analysis from EPIC, EPILOG and EPISTENT trials. Evaluation of 7E3 for the prevention of ischemic complications. Evaluation in percutaneous transluminal coronary angioplasty to improve long-term outcome with abciximab GP IIb/IIIa blockade. Evaluation of platelet IIb/IIIa Inhibitor for Stent J Am Coll Cardiol 36 2000 381 386
14. O.A. Razakjr, H.C. Tan, W.L. Yip, and Y.T. Lim Predictors of bleeding complications and thrombocytopenia with the use of abciximab during percutaneous coronary intervention J Interv Cardiol 18 2005 33 37
15. J.W. Eikelboom, S.R. Mehta, S.S. Anand, C. Xie, K.A. Fox, and S. Yusuf Adverse impact of bleeding on prognosis in patients with acute coronary syndromes Circulation 114 2006 774 782
16. S.V. Manoukian, F. Feit, R. Mehran, M.D. Voeltz, R. Ebrahimi, M. Hamon, G.D. Dangas, A.M. Lincoff, H.D. White, J.W. Moses, S.B. King 3rd, E.M. Ohman, and G.W. Stone Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial J Am Coll Cardiol 49 2007 1362 1368
17. A.M. Lincoff, J.A. Bittl, R.A. Harrington, F. Feit, N.S. Kleiman, J.D. Jackman, I.J. Sarembock, D.J. Cohen, D. Spriggs, R. Ebrahimi, G. Keren, J. Carr, E.A. Cohen, A. Betriu, W. Desmet, D.J. Kereiakes, W. Rutsch, R.G. Wilcox, P.J. de Feyter, A. Vahanian, and E.J. Topol Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial JAMA 289 2003 853 863
18. G.W. Stone, H.D. White, E.M. Ohman, M.E. Bertrand, A.M. Lincoff, B.T. McLaurin, D.A. Cox, S.J. Pocock, J.H. Ware, F. Feit, A. Colombo, S.V. Manoukian, A.J. Lansky, R. Mehran, and J.W. Moses Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis form the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial Lancet 369 2007 907 919
19. G.W. Stone, B. Witzenbichler, G. Guagliumi, J.Z. Peruga, B.R. Brodie, D. Dudek, R. Kornowski, F. Hartmann, B.J. Gersh, S.J. Pocock, G. Dangas, S.C. Wong, A.J. Kirtane, H. Parise, and R. Mehran Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 2008 2218 2230
20. A. Shahzad, I. Kemp, C. Mars, K. Wilson, C. Roome, R. Cooper, M. Andron, C. Appleby, M. Fisher, A. Khand, B. Kunadian, J.D. Mills, J.L. Morris, W.L. Morrison, S. Munir, N.D. Palmer, R.A. Perry, D.R. Ramsdale, P. Velavan, R.H. Stables HEAT-PPCI Trial Investigators Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial Lancet 384 2014 1849 1858
21. M.A. Cavender, and M.S. Sabatine Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trials Lancet 384 2014 599 606
22. G.W. Stone, M. Bertrand, A. Colombo, G. Dangas, M.E. Farkouh, F. Feit, A.J. Lansky, A.M. Lincoff, R. Mehran, J.W. Moses, M. Ohman, and H.D. White Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale Am Heart J 148 2004 764 775
23. R. Mehran, B. Brodie, D.A. Cox, C.L. Grines, B. Rutherford, D.L. Bhatt, G. Dangas, F. Feit, E.M. Ohman, H. Parise, M. Fahy, A.J. Lansky, and G.W. Stone The Harmonizing outcomes with RevasculariZatiON and stents in acute myocardial infarction (HORIZONS-AMI) trial: study design and rationale Am Heart J 156 2008 44 56
24. J.S. Hochman, C.H. McCabe, P.H. Stone, R.C. Becker, C.P. Cannon, T. DeFeo-Fraulini, B. Thompson, R. Steingart, G. Knatterud, and E. Braunwald Outcome and profile of women and men presenting with acute coronary syndromes: a report from TIMI IIIB J Am Coll Cardiol 30 1997 141 148
25. E.D. Peterson, A.J. Lansky, J. Kramer, K. Anstrom, and M.J. Lanzilotta Effect of gender on the outcomes of contemporary percutaneous coronary intervention Am J Cardiol 88 2001 359 364
26. M. Chacko, A.M. Lincoff, K.E. Wolski, D.J. Cohen, J.A. Bittl, A.J. Lansky, Y. Tsuchiya, A. Betriu, M.H. Yen, D.P. Chew, L. Cho, and E.J. Topol Ischemic and bleeding outcomes in women treated with bivalirudin during percutaneous coronary intervention: a subgroup analysis of the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial Am Heart J 151 2006 1032.e1 1032.e7
27. H.M. Sadeghi, G.W. Stone, C.L. Grines, R. Mehran, S.R. Dixon, A.J. Lansky, M. Fahy, D.A. Cox, E. Garcia, J.E. Tcheng, J.J. Griffin, T.D. Stuckey, M. Turco, and J.D. Carroll Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction Circulation 108 2003 2769 2775
28. R. Mehran, S. Pocock, E. Nikolsky, G.D. Dangas, T. Clayton, B.E. Claessen, A. Caixeta, F. Feit, S.V. Manoukian, H. White, M. Bertrand, E.M. Ohman, H. Parise, A.J. Lansky, A.M. Lincoff, and G.W. Stone Impact of bleeding on mortality after percutaneous coronary intervention: results from a patient-level pooled analysis of the REPLACE-2 (Randomized evaluation of PCI Linking angiomax to reduced clinical events), ACUITY (Acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (Harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials JACC Cardiovasc Interv 4 2011 654 664
29. C.M. Gibson, Y. Ten, S.A. Murphy, L.N. Ciaglo, M.C. Southard, A.M. Lincoff, and R. Waksman Association of prerandomization anticoagulant switching with bleeding in the setting of percutaneous coronary intervention (A REPLACE-2 analysis) Am J Cardiol 99 2007 1687 1690
30. G.D. Dangas, R. Mehran, E. Nikolsky, B.E. Claessen, A.J. Lansky, B.R. Brodie, B. Witzenbichler, G. Guagliumi, J.Z. Peruga, D. Dudek, M. Mockel, A. Caixeta, H. Parise, H. White, and G.W. Stone Effect of switching antithrombin agents for primary angioplasty in acute myocardial infarction: the HORIZONS-SWITCH analysis J Am Coll Cardiol 57 2011 2309 2316